Predicta Biosciences
About:
Predicta Biosciences uses multiomics and liquid biopsies in precision oncology to create innovative diagnostics and therapies.
Website: https://www.predictabiosciences.com
Top Investors: Engine Ventures, Illumina Ventures, BrightEdge - American Cancer Society, Time Partners Limited
Description:
Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages.
Total Funding Amount:
$5.2M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2023-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-07-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai